期刊
DERMATO-ENDOCRINOLOGY
卷 4, 期 1, 页码 2-7出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/derm.18681
关键词
vitamin D; statins; rosuvastatin; 25-hydroxyvitamin D serum levels
类别
An observational study and a clinical trial seem to prove that rosuvastatin (but not fluvastatin) dramatically increases serum levels of 25-(OH)-D3 (three-fold above starting values). A critical analysis of the two publications, presented below, raises serious concerns. Conclusions from these two studies have already been drawn in the scientific literature. It is argued that claiming or believing in a novel pleiotropic effect of rosuvastatin may be misleading and premature.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据